BioRestorative Therapies BRTX
NASDAQ BRTX
$1.57 +0.02 (+1.29%)
As of: Nov 11, 2026 · 3:59 PM EST

BioRestorative Therapies (BRTX) Other Operating Expenses (2010 - 2021)

Updated

BioRestorative Therapies (BRTX) posted Other Operating Expenses of $1.92 million for Q1 2026, down 27.4% from $2.64 million a year earlier and down 26.9% from the prior quarter.

Analysis

BioRestorative Therapies (BRTX) Other Operating Expenses (2010 - 2021) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Other Operating Expenses at BioRestorative Therapies was $9.35 million, up 29.3% year-over-year; for FY2025, it was $10.07 million, up 50.8% from FY2024.

  • Annual Other Operating Expenses has increased for four consecutive years, with a five-year compound annual growth rate of 57.4% (FY2020 to FY2025).
  • In prior years, BioRestorative Therapies' Other Operating Expenses was $6.68 million in FY2024 (+65.5%), $4.03 million in FY2023 (+14.8%), $3.51 million in FY2022 (+381.9%) and $729,058 in FY2021 (-30.1%).
  • The Q1 2026 figure stands as the lowest quarterly Other Operating Expenses since Q4 2024.
  • On a year-over-year basis, Other Operating Expenses increased in seven of the last eight quarters, with growth averaging 63.0%.
  • The strongest year-over-year quarter for Other Operating Expenses in the past five years was Q2 2022, with growth of 537.1%; the weakest was Q2 2021, with a decline of 44.0%.
  • According to Business Quant data, Other Operating Expenses for the three prior quarters was $2.63 million (Q4 2025), $2.58 million (Q3 2025) and $2.22 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 BioRestorative Therapies 1.36 Mn -17.06 Mn 15,785.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 7,868.00
Mar 31, 2021 10,989.00
Dec 31, 2020 4.72 Mn
Sep 30, 2020 217,131.00
Jun 30, 2020 -3.32 Mn
Mar 31, 2020 -2.52 Mn
Dec 31, 2019 445,516.00
Sep 30, 2019 530,154.00
Jun 30, 2019 642,722.00
Mar 31, 2019 615,571.00
Dec 31, 2018 740,833.00
Sep 30, 2018 572,762.00
Jun 30, 2018 435,485.00
Mar 31, 2018 473,953.00
Dec 31, 2017 491,195.00
Sep 30, 2017 530,905.00
Jun 30, 2017 884,362.00
Mar 31, 2017 493,205.00
Dec 31, 2016 363,511.00
Sep 30, 2016 453,349.00
API Access

BioRestorative Therapies Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BRTX&period=max&api_key=YOUR_API_KEY